Saturday, May 25, 2013 Last update: 8:34 AM
Company Tech News as it Breaks
FluoroPharma Medical, Inc.
News articles for FluoroPharma Medical, Inc.:
Tuesday, April 30, 2013
- FluoroPharma Medical's CEO and Chairman, Thijs Spoor, to Present at Taglich Brothers 10th Annual Small Cap Equity Conference on May 7thMONTCLAIR, NJ--(Marketwired - April 30, 2013) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before ... read more
Monday, April 15, 2013
- FluoroPharma Announces Appointment of Dr. Joseph A. Pierro to the Board of DirectorsMONTCLAIR, NJ--(Marketwired - April 15, 2013) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease ... read more
Friday, March 22, 2013
- FluoroPharma Receives Patent on Metabolic Markers for PET and SPECT ImagingMONTCLAIR, NJ -- (Marketwire) -- 03/22/13 -- FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, announced today that it has received a patent covering ... read more
Thursday, February 28, 2013
- FluoroPharma Medical Announces Initial Data From Phase II Study for CardioPET(TM) (FCPHA)MONTCLAIR, NJ--(Marketwire - February 28, 2013) - FluoroPharma Medical, Inc. (OTCBB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease ... read more
Tuesday, January 22, 2013
- FluoroPharma Medical, Inc. to Present at Noble Financial ConferenceMONTCLAIR, NJ--(Marketwire - January 22, 2013) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection ... read more
Thursday, January 3, 2013
- FluoroPharma Medical Announces Phase II Study for BFPET(TM) (18)F-TPPMONTCLAIR, NJ--(Marketwire - January 03, 2013) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and ... read more
Wednesday, January 2, 2013
- FluoroPharma Medical, Inc. to Present at Two Conferences Next WeekMONTCLAIR, NJ--(Marketwire - January 02, 2013) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and ... read more
Friday, November 30, 2012
- FluoroPharma Announces Another Milestone for BFPET(TM) (18)F-TPPMONTCLAIR, NJ--(Marketwire - November 30, 2012) - FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and ... read more
Tuesday, November 20, 2012
- FluoroPharma Medical, Inc. Announces $1.5M Equity FinancingMONTCLAIR, NJ -- (Marketwire) -- 11/20/12 -- FluoroPharma Medical, Inc. (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today announced that it completed a private placement on ... read more
Wednesday, September 12, 2012
- FluoroPharma Raises Revenue Forecast Citing Tremendous Progress in PipelineMONTCLAIR, NJ -- (Marketwire) -- 09/12/12 -- FluoroPharma Medical, Inc. (OTCBB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today announced a significant increase in revenue forecast. This news ... read more
Tuesday, September 4, 2012
- FluoroPharma to Present at the Rodman & Renshaw Annual Global Investment ConferenceMONTCLAIR, NJ -- (Marketwire) -- 09/04/12 -- FluoroPharma Medical, Inc. (OTCBB: FPMI) (OTCQB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today announced that Thijs Spoor, President & ... read more
Wednesday, August 29, 2012
- FluoroPharma Retains Cameron Associates as Investor Relations AdvisorMONTCLAIR, NJ -- (Marketwire) -- 08/29/12 -- FluoroPharma Medical, Inc. (OTCBB: FPMI), a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today announced that they have retained Cameron Associates as ... read more